Many of the country’s top children’s health systems are facing stronger industry headwinds, resulting from declining birth rates, clinician shortages, changing reimbursement models, and inconsistent federal and state funding. It has become more difficult for children’s health systems to sustain a “Switzerland-like” model where they are viewed in the market as the default provider of pediatric care.
In America, like most other nations, there is a need to provide healthcare services to a substantial indigent/poor population that cannot afford adequate healthcare coverage. As a result, States and Counties across the country established public hospitals whose core mission is to both provide care to this demographic and train the next generation of providers.
“Financial incentives for cancer programs have never been under more scrutiny and pressure.”We’ve all heard similar grumblings. Reimbursement and regulatory changes over the last few years are negatively impacting the bottom lines of cancer programs everywhere. Whether it’s site neutrality or reimbursement cuts to 340B programs, cancer providers are being forced to do more with less.
The value of NCI Designation to health systems is rarely studied or quantified through a strategic lens. This article attempts to address a very fundamental question: What is the strategic value of NCI-Designation to health systems as defined by its ability to influence two key variables: 1) Scale (i.e volume and market share) and 2) Impact (i.e., outcomes and research).
For decades, AMCs were viewed as having a mission that resembled a “three-legged stool” – with clinical care, education and research all given equal importance. But as funding sources have evolved, most academic medical centers now resemble a “tricycle”, with clinical care functioning as the big wheel pulling the other two along. What happens to the tripartite mission if the clinical margin “well” starts to run dry?
AMC/FQHC partnerships are still relatively rare despite the vast number of benefits, though interest is growing rapidly given financial pressures. This article explores the benefits, challenges and opportunities associated with structuring such partnerships.
The implementation of Site Neutrality has profound financial implications on any hospital planning new investments in ambulatory locations off the main campus. However, the unintended consequences of Site Neutrality has resulted in new behaviors by hospitals and health systems which may not necessarily reduce overall costs in the long-run.
Maternal fetal intervention plays a key role in the field of pediatric medicine and must be appropriately supported as it continues to evolve. The burgeoning field faces tremendous headwinds, however, as these procedures are expensive, NIH research funding is limited, and the next generation of therapies will raise additional ethical concerns as genetics and cellular treatments are investigated. This article profiles several innovative care models that have successfully addressed these challenges.